CTDNEP1 and neoplasm: CTDNEP1 knockdown substantially increased the sensitivity of cells to drug combination treatment compared with control cells (Supplementary Fig. 15b–d), suggesting that this combined treatment more selectively inhibits the growth of CTDNEP1 deficient tumor cells.